Augusta residents researching adipose tissue banking have more to check than a price sheet. Georgia’s stem cell law now sets disclosure duties for clinicians, federal rules govern the facilities that handle tissue, and the FTC sets the evidence bar for health claims.
TLDR Verification comes before payment. Georgia law now requires a specific notice in any advertisement for unapproved human stem cell therapy, plus a signed consent form before the procedure. FDA registration is self-submitted and is not approval or endorsement. No adipose-derived product is FDA approved for any disease, and banking tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy or trial.
Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease, including any orthopedic or neurologic condition. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. No adipose-derived stem cell product currently has FDA approval for any disease. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.
Augusta sits in Richmond County and anchors its own metro area, the Augusta-Richmond County, GA-SC MSA. The Census Bureau put the city at 201,999 residents as of July 1, 2025. Augusta is about 138 miles east of Atlanta in a straight line, not an Atlanta suburb.
Scale is why verification matters. A peer-reviewed clinic census found that, as of March 2021, 1,480 U.S. businesses operating 2,754 clinics were selling purported stem cell treatments. Save My Fat is a connector and does not collect, process, store, or treat tissue.
What Georgia’s Stem Cell Law Requires a Provider to Tell You
Georgia requires two disclosures: a specific notice in any advertisement for unapproved human stem cell therapy, and a signed consent form before the procedure. Both come from HB 1275 (2026 Ga. Laws Act 453), effective July 1, 2026. See the enrolled bill text and our Georgia stem cell law breakdown.
The notice must appear in full:
> THIS NOTICE MUST BE PROVIDED TO YOU UNDER GEORGIA LAW. This physician or his or her designee performs one or more human stem cell therapies that have not yet been approved by the FDA. You are encouraged to consult with your primary care provider before undergoing any human stem cell therapy.
It must be clearly legible and no smaller than the largest type in the advertisement. Consent must be signed first, in language the patient can reasonably understand, covering the treatment’s nature and character, the fact that it is not yet FDA approved, and the anticipated results.
The law approves nothing. It reaches a physician, or a physician assistant or nurse practitioner acting on that physician’s lawful designation, and its only penalty is discipline by the licensee’s professional board. Federal rules apply here as in every other state.
Why FDA Registration Is Not FDA Approval
Registration means a firm submitted its own information to FDA. It is not approval, endorsement, clearance, or certification, and FDA says so on its patient information page: “the fact that a firm has registered with FDA and listed its product does not mean the product is legally marketed.”
Check it anyway. Registration is required. Under 21 CFR 1271.21, an establishment must register and list within five days of beginning operations, and update annually each December. The tissue establishment database is searchable.
Georgia’s law points at the same records. Cells must be retrieved, manufactured, and stored in an FDA-registered facility, in Georgia or elsewhere, or in one certified and accredited by a qualifying body such as the American Association of Tissue Banks. Ask where your tissue would go, then verify the company.
Red Flags That Point to a Non-Compliant Clinic
The clearest red flag is a business charging you for a cell product outside a clinical trial. The FDA guidance for patients is blunt: “If you are being charged for these products or offered these products outside of a clinical trial, you are likely being deceived and offered a product illegally.” Three more patterns recur.
The first is named disease claims. FDA’s consumer alert says no regenerative medicine products are approved for COVID-19, orthopedic conditions, neurological disorders, cardiovascular or pulmonary disease, autism, blindness, or chronic pain. The second is marketing that outruns the paperwork. The rule turns on “labeling, advertising, or other indications of the manufacturer’s objective intent” at 21 CFR 1271.10(a). Across five 2025 and 2026 letters in FDA’s warning letter database, four turned on advertising and website copy.
The third is no notice and no consent form. Our fake clinic warning signs guide covers more of these gaps.
The Evidence Standard Behind Any Health Claim
A business must hold competent and reliable scientific evidence before making a health claim. The FTC’s health products compliance guidance defines that as “tests, analyses, research, or studies” evaluated objectively by experts in the relevant condition and “generally accepted in the profession to yield accurate and reliable results.”
Randomized, controlled human trials are the most reliable evidence and generally what experts require for a health benefit claim. Anecdotes and consumer surveys are never sufficient. A “results not typical” disclaimer does not correct a deceptive claim, and the FTC endorsement guides are direct: “Consumer endorsements themselves are not competent and reliable scientific evidence.”
In an action the FTC brought jointly with the Georgia Attorney General, a federal court granted summary judgment for the plaintiffs on all five counts. Relief orders filed in December 2024 totaled $5,155,146: $3,310,146 in restitution and $1,845,000 in civil penalties under the Georgia Fair Business Practices Act, per the FTC announcement.
Frequently Asked Questions
How can Augusta residents verify a provider before paying?
Start with records, not the website. Search the FDA tissue establishment database for the facility that would hold your tissue, remembering that a listing is self-submitted. Ask for the state advertising notice and the consent form in writing, and for the evidence behind any benefit described.
What is the realistic timeline from consultation to banked tissue?
No verified public benchmark exists, so treat any quoted turnaround as an estimate, not data. Timing depends on the clinician’s schedule, the collection date, and the laboratory’s intake process. Ask for the sequence in writing before you pay.
Does banking adipose tissue give me access to a future therapy?
No. Banking preserves your own tissue. No adipose-derived product is FDA approved for any disease, and any future use would depend on FDA regulatory status, physician guidance, and the pathways available at that time.
Key Takeaways
Verification is a records task, not a judgment call about a website. Georgia now requires an advertising notice and a signed consent form from clinicians who perform unapproved procedures, and its only penalty is professional discipline. It approved no therapy. FDA registration is self-submitted and proves only that a firm filed. The FTC requires competent and reliable scientific evidence before any health claim. Adipose-derived products remain investigational and are not FDA approved for any disease.
Save My Fat operates as a tissue preservation service, not a medical practice or treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, and Nevada governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.
Readers weighing adipose tissue banking for potential future use can review current pricing or ask a question through the contact page.
Save My Fat partners with L2 Bio for laboratory processing and storage.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review including neurology and neurosurgery input is required before publication. Please consult your neurologist or neurosurgeon before making any decisions about adipose tissue banking or research participation.
About the author: Oscar Tellez is the founder and CEO of Save My Fat. He holds a Bachelor of Science in Exercise Science and Health Promotion from Florida Atlantic University. He has spent more than a decade in the regenerative medicine industry across product distribution, laboratory and vendor relationships, and provider training. He is not a licensed clinician, and this article is educational, not medical advice.
Related guide: compliant marketing standards.
